Alon_R Posted - 57 minutes from now

$XERS **Highly important reminder** Xeris Biopharma should meet the FDA these days, in regard to advancement to Phase III of XP-8121 Hereby a quote of Xeris management -> FDA End-of-Phase 2 meeting anticipated **by the end of the year**

meistermell Posted - 49 minutes from now

$ESPR $XERS very =>

SparkyReturns Posted - 35 minutes from now

$XERS Hey folks I’m still here and heavily invested but I’ve been chasing a few other unicorns lately. Looks like the train is moving down the track to profitability as always. This is still my largest holding and plan to keep holding for a long time. I have some SNOW so that was fun. XERS will also have its day. Cheers!

Alon_R Posted - 24 minutes from now

$XERS ~Plenty of catalysts~ Profitability soon - nearly definite ✔️ XP-8121 ph3 soon - very likely ✔️ Regeneron deal soon - good probability ✔️ It might not be "now or never", but it might be the difference between one digit sp purchase to two digits sp purchase

HorizonBull Posted - 22 minutes ago

$XERS added 2k

Finwizard61 Posted - 24 minutes ago

$XERS Hmm she’s holding strong., waiting for a dip if any to top up my holding. Watching like a hawk. Can’t wait till March 2025!!

LionFox Posted - 46 minutes ago

$XERS whats the board thinking regarding the timing of a Regeneron update? Been so busy going broke, I forgot.

Alon_R Posted - 2 hours ago

$XERS Self sustained Profitable Xeris Biopharma, was in a sight distance, now it's already in a touch distance ✔️ I personally think, one better have it while Xeris getting very close to being profitable, rather than to have it while it'll be already announced, as it possibly leap double or quadruple, at that very moment (or based on forward looking till then) ✔️ Recorlev, or as I named it since it latest gigantic leap, "Recordlev" and the fact Xeris is already -0.06$ and should be next Quarter -0.04$ (before any further surprise which is very logical option), it's a poweful catalyst ✔️ Glta🖖

SimonSez4 Posted - 3 hours ago

$XERS luckily I sold this a month ago at 3.30. 4 years here of nothing. Put a quarter of the remaining proceeds into MSTR and have nearly completely made up my loss here. Sure wish I’d have dumped it all in. Michael Saylor gonna hopefully make me a lot more money. GL to the longs here who have dealt with nothing but frustration for these last few years. I just didn’t want to wait any longer hoping for a payoff.

acinvestor13 Posted - 10 hours ago

$XERS imagine if you just invested in BTC instead of a cash burning pharma with no cost discipline, churning mgmt, and a distant and fragile-at best-pipeline

BuyThisOne Posted - 14 hours ago

$XERS I love how they used a picture of an actual patient on page 6 of their presentation. The tattoo on her arm is Cortisol. If you are still willing to short this company after seeing how this company helps people you are a soulless creep.

Ithaca2018 Posted - 14 hours ago

$XERS Higher Lows! I love my Princess!

BuyThisOne Posted - 15 hours ago

$XERS For those of us here for 4 years or longer we have watched this company merge with another company, get 2 drugs approved and sign several technology deals and collaborations. It has been a bitter ride for many from $20 down to $1 and then steady up and downs since then. Sales have gone from zero to now almost $60 million a quarter. $200 million for 2024. $250 million for 2025? $280 million plus for 2026. For those of us lucky enough to be able to load up at $1 and up to the current price, things are feeling pretty good here. This company has honest roots in focusing on patients first and profits second. This is something to be proud of. What a crazy year with news that they thought they would only increase sales $7 million from 2023 or $170 million for the year. Yet here we are with 2 signed tech deals that have great potential and $200 million in revenue for the year. cont.

Nizmeister Posted - 19 hours ago

$XERS another day, another Gvoke script. Patient got one last year and md sending another today. love to see it.

mcube1820 Posted - 20 hours ago

$XERS I wonder if we're starting to see a bit of a rotation into small cap bios, despite RFK who has, I think, other more prominent targets in his sights. Just a thought.

acinvestor13 Posted - 21 hours ago

$XERS Lol for the 500th time in the history of this board, everyone getting excited that “something big is coming” since they didnt update the investor deck. How about their IR team just SUCKS!!

Bearly_Bullish_Trader Posted - 21 hours ago

$XERS Good days incoming:

TymeTryethTroth Posted - 23 hours ago

$XERS Simple confirmation that we’re going to get advancement updates on partner programs in the near future and all is going according to plan.

Finwizard61 Posted - 23 hours ago

$XERS Picked up another 1,000 shares today. Something is definitely cooking in the Xeris World.

TD_ Posted - 1 day ago

$XERS "PIPELINE WITH BLOCKBUSTER POTENTIAL" "Phase 3-ready XP-8121 – 1st and only, once-weekly, subcutaneous injection of levothyroxine for hypothyroidism, a >$1 billion market" "Multiple early-stage programs leveraging Xeris’ technology platforms for partners"

TD_ Posted - 1 day ago

$XERS Presentation. Formatting error on pg3...but i have not gone through it in detail yet. https://xerispharma.com/static-files/70a48b08-836c-40a2-ae7b-9743b1674c05

Alon_R Posted - 1 day ago

$XERS The Huge story over here is Self Sustainability and profitable Quarters very likely already 2025 (Q 4, 2024 should be around -0.04$). It is much faster than anyone thought of and related to the Huge leap of Recorlev (treatment of high coristol), that looks like it only going to leap further more. 2026 should be already profitable year, from first Q and so on. Companies in that spectrum (with financial status as Xeris+/-), already leap in that stage to around 20-25$ It's an immense opportunity right now, As I see it. It's better to have it under 10$ in a matter to enjoy the intensity of the growth, but many(likely most) will buy it above 10$ (Fair enough).

Brodman Posted - 1 day ago

$XERS Always love the the optimistic view of $30-$40 dollar stock....yet it can't hold $3 and hasn't seen $4 in years....but $30-$40 is in the cards. Keep dreaming.

mcube1820 Posted - 1 day ago

$XERS Manipulators hard at work to push it down back below $3.00.

therealpoub Posted - 1 day ago

$XERS interesting the latest presentation has not been posted on their website. Took the old one down and left us to wonder if there isn’t something huge coming….

BuyThisOne Posted - 1 day ago

$XERS Gvoke should work its way up to at least $250 million in revenue. Recorlev is looking like $300 million. So $550 million just with those 2. If Keveyis can maintain at $10 million a qtr that's another $40 million. So $600 million a year with current marketed drugs and other income. Add another $300 million minimum for Levo and we are getting closre to a billion a year in revenue. That should be good for $30-$40 a share. Add in partnership revenue that should also hit as Gvoke and Recorlev hit peak revenue and it is not hard to see $50-$60 a share in the early 2030's. Rarely are you given such a clear path to success as Xeris. Do your own research here and make a choice. I have made mine. -

Alon_R Posted - 1 day ago

$XERS Xeris Biopharma's Gvoke HypoPen included in the DoD(Department of Defense) inventory for treating Hypoglycemia. Is there more specific data we can find, like Quarterly or Yearly numbers?

Ithaca2018 Posted - 1 day ago

$XERS Something is about to happen, no idea what it is. It's been so long! Omg! Trials, Partnerships, upfront payment's? Is anyone going to use our tech? Amgen in trials, Regeneron? Let's go! Will we hear from you? We shall see:)

Ithaca2018 Posted - 1 day ago

$XERS Princess!

Universaal Posted - 1 day ago

$XERS very impressive close